Kobe University Hospital-Site Number : 3920010

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease	Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder	Recruiting	Phase 3	2026-09-23		NCT07190196

Clinical trials